Latest liver disease Stories
TEL AVIV, Israel, Jan. 6, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
Dignity Sciences today announced positive results with its anti-fibrotic compound DS102 in preclinical studies which assessed its potential effectiveness for the treatment of non-alcoholic steatohepatitis
PERTH, Australia, Nov.
TEL AVIV, Israel, Nov. 5, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
SOUTH SAN FRANCISCO, Calif., Oct.
Researchers at the University of Missouri School of Medicine have identified epigenetic protein changes caused by binge drinking, a discovery that could lead to treatments for alcohol-related liver diseases.
CF102 has shown to induce healthy liver cell proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept.
Transparency Market Research published a new report "Liver Diseases Therapeutics Market: Global Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" to its report store.
TEL AVIV, Israel, July 22, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
The Fatty Liver Bible & Ezra Protocol review that was just updated by Vkool.com reveals Debra Elkin’s home treatment system that promises efficiency in treating fatty liver and obesity.